back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-13 17:17 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
475,000 | |
| Filed 2024-09-13 17:14 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
475,000 | |
| Filed 2024-09-13 17:11 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
672,730 | |
| Filed 2024-09-13 17:09 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
672,730 | |
| Filed 2024-09-13 17:03 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
2,576,860 | |
| Filed 2024-09-13 16:59 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
2,138,000 | |
| Filed 2024-09-13 16:30 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$56,400
+600,000 vol $0.094 each |
1,926,860 | |
| Filed 2024-09-05 13:14 Tx date 2024-09-05 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+50,000 vol $0.10 each |
1,362,313 | |
| Filed 2024-08-14 13:23 Tx date 2024-08-14 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,207
+49,500 vol $0.085 each |
1,546,284 | |
| Filed 2024-07-18 17:38 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+150,000 vol |
626,200 | |
| Filed 2024-07-18 17:37 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+300,000 vol $0.10 each |
386,498 | |
| Filed 2024-07-18 17:34 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+150,000 vol |
626,200 | |
| Filed 2024-07-18 17:33 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+300,000 vol $0.10 each |
1,312,313 | |
| Filed 2024-07-18 17:30 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+150,000 vol |
626,200 | |
| Filed 2024-07-18 17:29 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+300,000 vol $0.10 each |
822,798 | |
| Filed 2024-07-18 17:24 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+150,000 vol |
626,200 | |
| Filed 2024-07-18 17:22 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+300,000 vol $0.10 each |
1,868,335 | |
| Filed 2024-07-18 15:27 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+150,000 vol |
697,630 | |
| Filed 2024-07-18 15:25 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+300,000 vol $0.10 each |
1,496,784 | |
| Filed 2024-07-15 17:14 Tx date 2024-07-03 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$5,983
+55,609 vol $0.1076 each |
86,498 | |
| Filed 2024-07-15 17:12 Tx date 2024-07-03 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$5,983
+55,609 vol $0.1076 each |
1,568,335 | |
| Filed 2024-07-15 17:09 Tx date 2024-07-03 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$5,983
+55,609 vol $0.1076 each |
522,798 | |
| Filed 2024-07-15 17:04 Tx date 2024-07-03 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$5,983
+55,609 vol $0.1076 each |
1,012,313 | |
| Filed 2024-07-15 16:27 Tx date 2024-07-03 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$6,881
+63,951 vol $0.1076 each |
1,196,784 | |
| Filed 2024-06-14 12:43 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-4,609,695 vol |
0 | |
| Filed 2024-06-14 12:40 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-452,429 vol |
476,200 | |
| Filed 2024-06-14 12:36 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-781,429 vol |
476,200 | |
| Filed 2024-04-15 12:40 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
+4,609,695 vol |
||
| Filed 2024-04-15 12:34 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
+452,429 vol |
||
| Filed 2024-04-15 12:26 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
+781,429 vol |
||
| Filed 2024-05-28 16:23 Tx date 2024-05-27 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$566.70
+6,667 vol $0.085 each |
6,667 | |
| Filed 2024-05-28 16:23 Tx date 2023-05-12 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-28 16:21 Tx date 2024-05-27 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,667 vol |
213,333 | |
| Filed 2024-05-22 17:05 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,953
+31,091 vol $0.095 each |
467,189 | |
| Filed 2024-05-17 13:19 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,536
+31,091 vol $0.95 each |
||
| Filed 2024-05-18 19:12 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-38,834 vol |
137,455 | |
| Filed 2024-05-18 19:10 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
58 - Expiration of rights
|
-38,834 vol |
176,289 | |
| Filed 2024-05-18 19:07 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,689
+38,834 vol $0.095 each |
1,132,833 | |
| Filed 2024-05-17 13:19 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,536
+31,091 vol $0.95 each |
467,189 | |
| Filed 2024-05-17 13:17 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-31,091 vol |
104,729 | |
| Filed 2024-05-17 13:15 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
58 - Expiration of rights
|
-31,091 vol |
135,820 | |
| Filed 2024-05-17 13:11 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,689
+38,834 vol $0.095 each |
956,704 | |
| Filed 2024-05-17 13:10 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-38,834 vol |
189,274 | |
| Filed 2024-05-17 13:08 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
58 - Expiration of rights
|
-38,834 vol |
228,108 | |
| Filed 2024-04-15 12:40 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
+4,609,695 vol |
9,219,390 | |
| Filed 2024-04-15 12:34 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
+452,429 vol |
1,381,058 | |
| Filed 2024-04-15 12:26 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
+781,429 vol |
2,039,058 | |
| Filed 2024-04-15 11:25 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-345,000 vol |
547,630 | |
| Filed 2024-04-02 17:13 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,163 vol |
537,161 | |
| Filed 2024-04-02 17:10 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,530
+37,163 vol $0.095 each |
1,093,999 | |
| Filed 2024-04-02 16:44 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,530
+37,163 vol $0.095 each |
917,870 | |
| Filed 2024-04-02 16:42 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,163 vol |
535,343 | |
| Filed 2024-04-02 16:40 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,738
+28,828 vol $0.095 each |
70,922 | |
| Filed 2024-04-02 16:38 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,828 vol |
135,462 | |
| Filed 2024-04-02 16:36 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,316
+34,910 vol $0.095 each |
436,098 | |
| Filed 2024-04-02 16:34 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-34,910 vol |
555,637 | |
| Filed 2024-04-02 16:32 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,738
+28,828 vol $0.095 each |
1,512,726 | |
| Filed 2024-04-02 16:30 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,828 vol |
135,462 | |
| Filed 2024-03-13 14:08 Tx date 2024-03-07 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$666.70
+6,667 vol $0.10 each |
30,889 | |
| Filed 2024-03-13 14:06 Tx date 2024-03-07 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,667 vol |
213,333 | |
| Filed 2024-01-09 19:25 Tx date 2024-01-09 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,650
+70,000 vol $0.095 each |
401,188 | |
| Filed 2024-01-02 16:58 Tx date 2023-12-29 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$2,695
+24,222 vol $0.1113 each |
24,222 | |
| Filed 2024-01-02 16:57 Tx date 2023-02-21 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-02 16:56 Tx date 2023-12-29 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$2,695
+24,222 vol $0.1113 each |
331,188 | |
| Filed 2024-01-02 16:53 Tx date 2023-12-29 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$2,695
+24,222 vol $0.1113 each |
880,707 | |
| Filed 2024-01-02 16:50 Tx date 2023-12-29 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$2,695
+24,222 vol $0.1113 each |
1,483,898 | |
| Filed 2024-01-02 15:56 Tx date 2023-12-29 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$3,100
+27,855 vol $0.1113 each |
1,056,836 | |
| Filed 2023-11-30 18:07 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
574,324 | |
| Filed 2023-11-30 18:05 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,326,860 | |
| Filed 2023-11-30 17:36 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,538,000 | |
| Filed 2023-11-30 17:35 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
590,547 | |
| Filed 2023-11-30 17:33 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,450,000 vol |
1,776,860 | |
| Filed 2023-11-30 17:31 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+550,000 vol |
572,506 | |
| Filed 2023-11-30 17:29 Tx date 2023-11-29 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,750
+50,000 vol $0.075 each |
856,485 | |
| Filed 2023-11-30 17:15 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
220,000 | |
| Filed 2023-11-30 17:14 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
220,000 | |
| Filed 2023-11-30 17:12 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
164,290 | |
| Filed 2023-11-30 17:09 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
164,290 | |
| Filed 2023-10-12 15:54 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+547,630 vol |
892,630 | |
| Filed 2023-10-12 12:20 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
16 - Acquisition or disposition under a prospectus exemption
|
$
+$115 vol $1,000 each |
$115 | |
| Filed 2023-10-12 12:19 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 14:05 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+476,200 vol |
476,200 | |
| Filed 2023-10-11 14:04 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 14:03 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
11 - Acquisition or disposition carried out privately
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2023-10-11 14:01 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 14:00 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+476,200 vol |
476,200 | |
| Filed 2023-10-11 13:58 Tx date 2023-02-21 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 13:57 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
11 - Acquisition or disposition carried out privately
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2023-10-11 13:56 Tx date 2023-02-21 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 13:54 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+476,200 vol |
928,629 | |
| Filed 2023-10-11 13:52 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
11 - Acquisition or disposition carried out privately
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2023-10-11 13:50 Tx date 2020-04-07 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 13:33 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+476,200 vol |
1,257,629 | |
| Filed 2023-10-11 13:20 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
11 - Acquisition or disposition carried out privately
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2023-10-11 13:12 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-26 14:03 Tx date 2023-05-25 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2023-05-26 14:02 Tx date 2023-05-12 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-26 14:00 Tx date 2023-05-24 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2023-05-26 13:58 Tx date 2023-05-12 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-12 13:25 Tx date 2023-05-11 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$795.84
+6,632 vol $0.12 each |
77,693 | |
| Filed 2023-05-12 13:23 Tx date 2023-05-11 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
64,290 | |
| Filed 2023-05-02 15:30 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-20,728 vol |
90,547 | |
| Filed 2023-05-02 15:27 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-20,728 vol |
||
| Filed 2023-05-02 15:26 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
111,275 | ||
| Filed 2023-05-02 15:23 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
538,000 | ||
| Filed 2023-05-01 13:17 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-20,728 vol |
||
| Filed 2023-05-01 13:15 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-04 10:52 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-04 10:47 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-01 13:40 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
416,665 | |
| Filed 2023-05-01 13:39 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
402,387 | |
| Filed 2023-05-01 13:37 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,368
+25,910 vol $0.13 each |
806,485 | |
| Filed 2023-05-01 13:36 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-25,910 vol |
22,506 | |
| Filed 2023-05-01 13:34 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,041
+31,092 vol $0.13 each |
4,200,420 | |
| Filed 2023-05-01 13:33 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-31,092 vol |
54,934 | |
| Filed 2023-05-01 13:31 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
533,465 | |
| Filed 2023-05-01 13:30 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
64,290 | |
| Filed 2023-05-01 13:28 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
42,094 | |
| Filed 2023-05-01 13:26 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
64,290 | |
| Filed 2023-05-01 13:23 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
1,459,676 | |
| Filed 2023-05-01 13:23 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$862.16
+6,632 vol $0.13 each |
||
| Filed 2023-05-01 13:21 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$862.16
+6,632 vol $0.13 each |
||
| Filed 2023-05-01 13:18 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,694
+20,728 vol $0.13 each |
306,966 | |
| Filed 2023-05-01 13:17 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-20,728 vol |
49,092 | |
| Filed 2023-05-01 13:15 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
69,820 | ||
| Filed 2023-05-01 12:43 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
64,290 | |
| Filed 2023-05-01 12:01 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
777,693 | |
| Filed 2023-05-01 11:55 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,368
+25,910 vol $0.13 each |
1,028,981 | |
| Filed 2023-05-01 11:53 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
763,265 | |
| Filed 2023-05-01 11:53 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
||
| Filed 2023-05-01 11:52 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-25,910 vol |
215,123 | |
| Filed 2023-05-01 11:47 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-862.16
-6,632 vol $0.13 each |
6,633 | |
| Filed 2023-04-04 10:52 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-13 14:11 Tx date 2023-04-13 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+40,000 vol $0.11 each |
1,003,071 | |
| Filed 2023-04-05 16:15 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
| Filed 2023-04-05 16:14 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 16:13 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
| Filed 2023-04-05 16:13 Tx date 2021-05-07 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 16:11 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
| Filed 2023-04-05 16:10 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 16:09 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
| Filed 2023-04-05 16:08 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 16:06 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
| Filed 2023-04-05 16:05 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 15:58 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+640,000 vol |
640,000 | |
| Filed 2023-04-05 15:56 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 14:47 Tx date 2023-04-05 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+100,000 vol $0.099 each |
780,575 | |
| Filed 2023-04-04 10:52 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
11,275 | ||
| Filed 2023-04-04 10:47 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
53,800 | ||
| Filed 2023-04-04 10:43 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
166,911 | ||
| Filed 2023-04-04 10:39 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Choudhary, Patricia Ranija
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
286,238 | ||
| Filed 2023-03-31 13:50 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
410,033 | |
| Filed 2023-03-31 13:49 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
409,019 | |
| Filed 2023-03-31 13:46 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-412,400 vol |
326,860 | |
| Filed 2023-03-31 13:42 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,067.13
-11,857 vol $0.09 each |
680,575 | |
| Filed 2023-03-31 13:41 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,158
+37,162 vol $0.085 each |
692,432 | |
| Filed 2023-03-31 13:39 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,162 vol |
48,416 | |
| Filed 2023-03-31 13:38 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,977
+58,559 vol $0.085 each |
4,169,328 | |
| Filed 2023-03-31 13:36 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-58,559 vol |
86,026 | |
| Filed 2023-03-31 13:35 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,296.09
-14,401 vol $0.09 each |
71,061 | |
| Filed 2023-03-31 13:34 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
85,462 | |
| Filed 2023-03-31 13:32 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
70,922 | |
| Filed 2023-03-31 13:30 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
526,833 | |
| Filed 2023-03-31 13:29 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
70,922 | |
| Filed 2023-03-31 13:27 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
35,462 | |
| Filed 2023-03-31 13:25 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
70,922 | |
| Filed 2023-03-31 13:23 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
1,453,044 | |
| Filed 2023-03-31 13:21 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
70,922 | |
| Filed 2023-03-31 13:02 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,296.09
-14,401 vol $0.09 each |
771,061 | |
| Filed 2023-03-31 13:01 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
785,462 | |
| Filed 2023-03-31 12:57 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-2,450.465
-28,829 vol $0.085 each |
57,657 | |
| Filed 2023-03-31 12:40 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+37,162 vol |
963,071 | |
| Filed 2023-03-31 12:39 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
36 - Conversion or exchange
|
-37,162 vol |
74,324 | |
| Filed 2023-03-31 12:31 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-721,700
-412,400 vol $1.75 each |
326,860 | |
| Filed 2023-03-30 11:29 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-231,052 vol |
131,170 | |
| Filed 2023-03-30 11:25 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-86,174 vol |
0 | |
| Filed 2023-03-30 11:24 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-86,174 vol |
437,848 | |
| Filed 2023-03-30 11:22 Tx date 2023-03-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-76,388 vol |
417,730 | |
| Filed 2023-03-10 16:20 Tx date 2023-03-08 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2023-03-10 16:00 Tx date 2023-02-21 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-10 15:58 Tx date 2023-03-08 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2023-03-10 15:52 Tx date 2023-02-21 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-26 12:26 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+338,097 vol |
524,022 | |
| Filed 2023-01-26 12:24 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,174 vol |
185,925 | |
| Filed 2023-01-26 12:20 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+86,174 vol |
86,174 | |
| Filed 2023-01-26 12:12 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-26 12:10 Tx date 2022-12-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+76,388 vol |
494,118 | |
| Filed 2022-11-14 10:37 Tx date 2022-11-11 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,500
+100,000 vol $0.135 each |
381,204 | |
| Filed 2022-11-10 15:38 Tx date 2022-11-10 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,750
+50,000 vol $0.135 each |
655,270 | |
| Filed 2022-09-20 15:44 Tx date 2022-09-20 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,900
+40,000 vol $0.1225 each |
605,270 | |
| Filed 2022-09-16 15:07 Tx date 2022-09-16 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+50,000 vol $0.14 each |
56,633 | |
| Filed 2022-09-15 16:26 Tx date 2022-09-15 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,150
+90,000 vol $0.135 each |
565,270 | |
| Filed 2022-09-14 14:42 Tx date 2022-09-14 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,499
+100,000 vol $0.145 each |
4,110,769 | |
| Filed 2022-09-13 16:47 Tx date 2022-09-09 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,650
+30,000 vol $0.155 each |
475,270 | |
| Filed 2022-09-07 17:26 Tx date 2022-09-07 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,500
+500,000 vol $0.125 each |
1,424,215 | |
| Filed 2022-08-25 14:09 Tx date 2022-08-25 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+200,000 vol $0.11 each |
925,909 | |
| Filed 2022-08-25 13:06 Tx date 2022-08-25 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+250,000 vol $0.11 each |
503,122 | |
| Filed 2022-05-19 17:04 Tx date 2022-05-17 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,633 vol |
6,633 | |
| Filed 2022-05-19 17:04 Tx date 2021-05-07 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-19 17:03 Tx date 2022-05-17 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
| Filed 2022-05-05 17:43 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
756,633 | |
| Filed 2022-05-05 17:41 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-1,724.58
-6,633 vol $0.26 each |
13,265 | |
| Filed 2022-05-05 12:23 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,694
+10,364 vol $0.26 each |
253,122 | |
| Filed 2022-05-05 12:22 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-10,364 vol |
26,798 | |
| Filed 2022-05-05 12:20 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
281,204 | |
| Filed 2022-05-05 12:18 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
| Filed 2022-05-05 12:17 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,936.32
-8,068 vol $0.24 each |
445,270 | |
| Filed 2022-05-05 12:16 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,736
+25,909 vol $0.26 each |
453,338 | |
| Filed 2022-05-05 12:15 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-25,909 vol |
85,578 | |
| Filed 2022-05-05 12:13 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,083
+31,091 vol $0.26 each |
4,010,769 | |
| Filed 2022-05-05 12:12 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-31,091 vol |
144,585 | |
| Filed 2022-05-05 12:10 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
498,004 | |
| Filed 2022-05-05 12:09 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
| Filed 2022-05-05 12:08 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
6,633 | |
| Filed 2022-05-05 12:07 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-05 12:06 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
| Filed 2022-05-05 12:01 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
924,215 | |
| Filed 2022-05-05 12:00 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
| Filed 2022-05-05 10:03 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+25,909 vol |
725,909 | |
| Filed 2022-05-05 10:00 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-25,909 vol |
241,033 | |
| Filed 2022-04-25 14:33 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+175,676 vol |
175,676 | |
| Filed 2022-04-25 14:31 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+175,675 vol |
362,222 | |
| Filed 2022-04-25 14:23 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
| Filed 2022-04-25 14:21 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
417,730 | |
| Filed 2022-04-25 14:17 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
| Filed 2022-04-25 14:15 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
397,730 | |
| Filed 2022-04-25 14:13 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
| Filed 2022-04-25 14:12 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
329,730 | |
| Filed 2022-04-25 14:10 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
| Filed 2022-04-25 14:08 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
397,730 | |
| Filed 2022-04-25 14:06 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
| Filed 2022-04-25 14:03 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
397,730 | |
| Filed 2022-04-25 14:01 Tx date 2022-04-22 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
-100,000 vol |
739,260 | |
| Filed 2022-04-25 13:59 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+111,486 vol |
266,942 | |
| Filed 2022-04-25 13:58 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+111,487 vol |
111,487 | |
| Filed 2022-04-25 13:57 Tx date 2020-04-07 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-25 13:56 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
839,260 | |
| Filed 2022-04-25 13:54 Tx date 2022-04-22 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
-100,000 vol |
578,000 | |
| Filed 2022-04-25 13:44 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+37,162 vol |
99,344 | |
| Filed 2022-04-25 13:43 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+37,162 vol |
37,162 | |
| Filed 2022-04-25 13:42 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-25 13:40 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
678,000 | |
| Filed 2022-04-25 13:33 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
650,000 | |
| Filed 2022-04-25 13:31 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+175,675 vol |
||
| Filed 2022-04-25 13:31 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+175,675 vol |
362,222 | |
| Filed 2022-04-25 13:30 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+175,676 vol |
175,676 | |
| Filed 2022-04-25 13:30 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+175,676 vol |
||
| Filed 2022-04-25 13:26 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-25 13:06 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+28,829 vol |
86,486 | |
| Filed 2022-04-25 13:04 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+28,828 vol |
57,657 | |
| Filed 2022-04-25 13:02 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+28,829 vol |
28,829 | |
| Filed 2022-04-25 12:53 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-25 12:47 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+129,730 vol $0.37 each |
397,730 | |
| Filed 2022-04-25 11:40 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+111,486 vol |
111,486 | |
| Filed 2022-04-25 11:39 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-25 11:37 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+111,486 vol |
266,942 | |
| Filed 2022-04-25 11:28 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,430
+50,000 vol $0.3686 each |
839,260 | |
| Filed 2022-04-25 11:20 Tx date 2022-04-22 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-175,000
-100,000 vol $1.75 each |
739,260 | |
| Filed 2021-12-01 14:33 Tx date 2021-12-01 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,750
+50,000 vol $0.435 each |
3,979,678 | |
| Filed 2021-10-18 14:14 Tx date 2021-10-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,162
+7,853 vol $0.53 each |
700,000 | |
| Filed 2021-10-15 16:05 Tx date 2021-10-15 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,590
+3,000 vol $0.53 each |
692,147 | |
| Filed 2021-09-27 16:18 Tx date 2021-09-27 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,000
+50,000 vol $0.56 each |
750,000 | |
| Filed 2021-09-22 11:47 Tx date 2021-09-22 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,000
+100,000 vol $0.60 each |
3,929,678 | |
| Filed 2021-08-31 11:50 Tx date 2021-08-31 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,830
+7,000 vol $0.69 each |
689,147 | |
| Filed 2021-08-11 16:49 Tx date 2021-08-11 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,555
+3,500 vol $0.73 each |
682,147 | |
| Filed 2021-06-29 11:55 Tx date 2021-06-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,056
+12,800 vol $1.02 each |
700,000 | |
| Filed 2021-06-29 11:54 Tx date 2021-06-25 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,372
+17,200 vol $1.01 each |
687,200 | |
| Filed 2021-05-18 09:26 Tx date 2021-05-12 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+19,898 vol |
19,898 | |
| Filed 2021-05-17 17:10 Tx date 2021-05-12 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+19,898 vol |
||
| Filed 2021-05-17 17:10 Tx date 2021-05-12 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+19,898 vol |
19,898 | |
| Filed 2021-05-17 17:07 Tx date 2021-05-07 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-17 17:06 Tx date 2021-05-12 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2021-05-17 13:18 Tx date 2021-05-07 |
$WLLW
Willow Biosciences Inc. |
Munroe, Barbara Elaine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 19:06 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+62,182 vol |
62,182 | |
| Filed 2021-05-03 19:06 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 19:05 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$160,810
+100,000 vol $1.61 each |
628,000 | |
| Filed 2021-05-03 19:00 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+19,898 vol |
19,898 | |
| Filed 2021-05-03 19:00 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:59 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,188
+48,000 vol $1.61 each |
288,000 | |
| Filed 2021-05-03 18:55 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+155,456 vol |
155,456 | |
| Filed 2021-05-03 18:54 Tx date 2020-04-07 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:54 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$321,620
+200,000 vol $1.61 each |
789,260 | |
| Filed 2021-05-03 18:51 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+186,547 vol |
186,547 | |
| Filed 2021-05-03 18:50 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:50 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$804,050
+500,000 vol $1.61 each |
500,000 | |
| Filed 2021-05-03 18:49 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:47 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+155,456 vol |
155,456 | |
| Filed 2021-05-03 18:46 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:44 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+19,898 vol |
19,898 | |
| Filed 2021-05-03 18:43 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,188
+48,000 vol $1.61 each |
268,000 | |
| Filed 2021-05-03 18:42 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
30 - Acquisition or disposition under a purchase/ownership plan
|
$77,188
+48,000 vol $1.61 each |
||
| Filed 2021-05-03 18:41 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:40 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
30 - Acquisition or disposition under a purchase/ownership plan
|
$77,188
+48,000 vol $1.61 each |
||
| Filed 2021-05-03 18:37 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+19,898 vol |
19,898 | |
| Filed 2021-05-03 18:36 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:36 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,188
+48,000 vol $1.61 each |
268,000 | |
| Filed 2021-05-03 18:28 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+19,898 vol |
19,898 | |
| Filed 2021-05-03 18:27 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:25 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,188
+48,000 vol $1.61 each |
268,000 | |
| Filed 2021-05-03 18:01 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
268,000 | |
| Filed 2021-05-03 17:55 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+19,898 vol |
19,898 | |
| Filed 2021-05-03 17:46 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 17:19 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$322,000
+200,000 vol $1.61 each |
789,260 | |
| Filed 2021-04-08 18:08 Tx date 2021-03-01 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+40,000 vol |
427,429 | |
| Filed 2021-04-08 18:07 Tx date 2021-03-01 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-40,000 vol |
452,429 | |
| Filed 2021-03-04 19:07 Tx date 2021-03-01 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+1,000,000 vol |
26,048,476 | |
| Filed 2021-03-04 19:05 Tx date 2021-03-01 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-1,000,000 vol |
4,609,695 | |
| Filed 2021-03-02 13:03 Tx date 2021-03-01 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$125,375
+147,500 vol $0.85 each |
3,829,678 | |
| Filed 2021-03-02 13:01 Tx date 2021-03-01 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-147,500 vol |
1,256,156 | |
| Filed 2021-02-26 16:56 Tx date 2021-02-25 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$34,000
+40,000 vol $0.85 each |
670,000 | |
| Filed 2021-02-26 16:54 Tx date 2021-02-25 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-34,000
-40,000 vol $0.85 each |
347,000 | |
| Filed 2021-02-26 11:03 Tx date 2021-02-26 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$65,376
+76,913 vol $0.85 each |
678,647 | |
| Filed 2021-02-26 11:00 Tx date 2021-02-26 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-65,376.05
-76,913 vol $0.85 each |
345,000 | |
| Filed 2021-02-25 20:55 Tx date 2021-02-25 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$98,076
+115,384 vol $0.85 each |
917,582 | |
| Filed 2021-02-25 20:54 Tx date 2021-02-25 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-115,384 vol |
781,429 | |
| Filed 2020-11-02 16:08 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,600
+80,000 vol $0.62 each |
630,000 | |
| Filed 2020-11-02 16:06 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$2,400
+40,000 vol $0.06 each |
387,000 | |
| Filed 2020-10-30 18:48 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$4,614
+76,913 vol $0.06 each |
421,913 | |
| Filed 2020-10-30 18:44 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$95,372
+153,826 vol $0.62 each |
601,734 | |
| Filed 2020-10-30 18:40 Tx date 2019-05-27 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-9,219,390 vol |
4,609,695 | |
| Filed 2020-10-30 18:36 Tx date 2019-05-27 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-230,484,762 vol |
||
| Filed 2020-10-30 18:29 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-331,898,058 vol |
13,829,085 | |
| Filed 2020-10-30 17:58 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+115,384 vol |
896,813 | |
| Filed 2020-10-30 17:57 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$149,999
+230,769 vol $0.65 each |
802,198 | |
| Filed 2020-10-30 17:42 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+40,000 vol |
492,429 | |
| Filed 2020-10-30 17:41 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$52,000
+80,000 vol $0.65 each |
387,429 | |
| Filed 2020-10-30 17:36 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+147,307 vol |
1,403,656 | |
| Filed 2020-10-30 17:34 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$191,499
+294,615 vol $0.65 each |
3,682,178 | |
| Filed 2020-10-30 17:32 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+1,000,000 vol |
116,242,381 | |
| Filed 2020-10-30 17:29 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,300,000
+2,000,000 vol $0.65 each |
25,048,476 | |
| Filed 2019-05-28 14:31 Tx date 2019-05-27 |
$WLLW
Willow Biosciences Inc. |
Tuatara Capital Fund II, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-230,484,762 vol |
||
| Filed 2020-07-14 17:27 Tx date 2020-07-14 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,880
+4,000 vol $0.47 each |
447,908 | |
| Filed 2020-07-13 10:12 Tx date 2020-07-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+500 vol $0.50 each |
443,908 | |
| Filed 2020-06-30 15:07 Tx date 2020-06-30 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$940.00
+2,000 vol $0.47 each |
3,387,563 | |
| Filed 2020-06-30 15:07 Tx date 2020-06-30 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,280
+18,000 vol $0.46 each |
3,385,563 | |
| Filed 2020-06-29 17:23 Tx date 2020-04-07 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
452,429 | ||
| Filed 2020-06-29 17:22 Tx date 2020-04-07 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
589,260 | ||
| Filed 2020-06-29 17:21 Tx date 2020-04-07 |
$WLLW
Willow Biosciences Inc. |
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
307,429 | ||
| Filed 2020-06-26 13:24 Tx date 2020-06-26 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,800
+20,000 vol $0.44 each |
3,367,563 | |
| Filed 2020-06-22 17:52 Tx date 2020-06-22 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,640
+34,000 vol $0.46 each |
3,347,563 | |
| Filed 2020-06-22 17:52 Tx date 2020-06-22 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$430.00
+1,000 vol $0.43 each |
3,313,563 | |
| Filed 2020-06-10 19:20 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 19:19 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 19:17 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 19:16 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 19:15 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 19:13 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 19:12 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
240,000 | |
| Filed 2020-06-10 19:11 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
||
| Filed 2020-06-10 19:09 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
528,000 | |
| Filed 2020-06-10 19:07 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
||
| Filed 2020-06-10 18:24 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 18:24 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 18:21 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 18:21 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 18:16 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 18:16 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 17:40 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,200
+20,000 vol $0.41 each |
220,000 | |
| Filed 2020-06-10 17:37 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
240,000 | |
| Filed 2020-06-10 17:37 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
||
| Filed 2020-06-10 17:32 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
528,000 | |
| Filed 2020-06-10 17:32 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+48,000 vol |
||
| Filed 2020-06-10 17:21 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,512
+76,860 vol $0.41 each |
589,260 | |
| Filed 2020-06-10 17:16 Tx date 2020-06-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,500
+100,000 vol $0.365 each |
443,408 | |
| Filed 2020-06-04 16:10 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+25,000 vol $0.40 each |
343,408 | |
| Filed 2020-06-04 12:46 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,700
+35,000 vol $0.42 each |
3,312,563 | |
| Filed 2020-05-21 10:22 Tx date 2020-05-20 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+50,000 vol $0.42 each |
3,277,563 | |
| Filed 2020-02-21 09:35 Tx date 2020-02-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,000
+25,000 vol $0.68 each |
318,408 | |
| Filed 2019-12-05 17:40 Tx date 2019-11-29 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,000
+50,000 vol $0.62 each |
550,000 | |
| Filed 2019-11-06 11:37 Tx date 2019-11-05 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,600
+20,000 vol $0.68 each |
293,408 | |
| Filed 2019-11-04 17:18 Tx date 2019-11-04 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,000
+50,000 vol $0.72 each |
500,000 | |
| Filed 2019-10-31 15:23 Tx date 2019-10-31 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,000
+50,000 vol $0.74 each |
3,227,563 | |
| Filed 2019-10-28 13:34 Tx date 2019-10-28 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,000
+50,000 vol $0.76 each |
3,177,563 | |
| Filed 2019-10-25 15:29 Tx date 2019-10-25 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,179
+47,000 vol $0.75 each |
450,000 | |
| Filed 2019-10-25 15:16 Tx date 2019-10-22 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,950
+63,000 vol $0.65 each |
403,000 | |
| Filed 2019-10-21 12:00 Tx date 2019-10-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,450
+15,000 vol $0.63 each |
273,408 | |
| Filed 2019-10-07 22:02 Tx date 2019-10-07 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$30,150
+67,000 vol $0.45 each |
347,000 | |
| Filed 2019-10-07 17:19 Tx date 2019-10-07 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$65,250
+145,000 vol $0.45 each |
345,000 | |
| Filed 2019-10-07 17:06 Tx date 2019-10-07 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$94,500
+210,000 vol $0.45 each |
781,429 | |
| Filed 2019-10-07 16:48 Tx date 2019-10-07 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$139,500
+310,000 vol $0.45 each |
1,256,349 | |
| Filed 2019-10-07 16:41 Tx date 2019-10-07 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$54,000
+120,000 vol $0.45 each |
290,779 | |
| Filed 2019-09-18 12:36 Tx date 2019-09-18 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$199,999
+294,117 vol $0.68 each |
3,127,563 | |
| Filed 2019-08-19 12:05 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-31,577,143 vol |
1,315,714 | |
| Filed 2019-08-19 12:03 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
32,892,857 | ||
| Filed 2019-08-19 12:02 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-80,567,132 vol |
3,356,964 | |
| Filed 2019-08-19 11:58 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+83,174,096 vol |
83,924,096 | |
| Filed 2019-08-02 12:18 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-720,000 vol |
||
| Filed 2019-08-02 12:17 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-73,223,530 vol |
||
| Filed 2019-04-23 14:19 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+75,524,510 vol |
||
| Filed 2019-04-22 18:03 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-15 13:26 Tx date 2019-08-14 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,660
+9,000 vol $0.74 each |
2,833,446 | |
| Filed 2019-08-14 15:04 Tx date 2019-08-14 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,400
+20,000 vol $0.72 each |
340,000 | |
| Filed 2019-08-13 20:40 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-25,439,650 vol |
1,059,985 | |
| Filed 2019-08-13 20:35 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
26,499,635 | ||
| Filed 2019-08-13 17:05 Tx date 2019-08-07 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,960
+4,000 vol $0.74 each |
2,824,446 | |
| Filed 2019-08-13 17:04 Tx date 2019-07-31 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,850
+5,000 vol $0.77 each |
2,934,082 | |
| Filed 2019-08-13 17:02 Tx date 2019-07-29 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,360
+4,000 vol $0.84 each |
2,929,082 | |
| Filed 2019-08-13 14:20 Tx date 2019-08-01 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
-113,636 vol |
632,064 | |
| Filed 2019-08-13 14:19 Tx date 2019-08-01 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-113,636 vol |
2,811,446 | |
| Filed 2019-08-13 14:16 Tx date 2019-08-01 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+113,636 vol |
170,779 | |
| Filed 2019-08-13 14:14 Tx date 2019-08-01 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+113,636 vol |
242,758 | |
| Filed 2019-08-13 14:11 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,371,428 vol |
57,143 | |
| Filed 2019-08-13 14:07 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,498,935 vol |
104,122 | |
| Filed 2019-08-13 14:03 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,603,057 | ||
| Filed 2019-08-13 13:43 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,428,571 | ||
| Filed 2019-08-13 13:38 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-13 13:38 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,342,857 | ||
| Filed 2019-08-02 11:24 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-17,896,792 vol |
||
| Filed 2019-07-31 16:56 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-31 16:56 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-22 21:27 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-08 13:00 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-08 12:56 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000,000 vol |
5,000,000 | |
| Filed 2019-08-08 12:55 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-08 10:49 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-11,520,000 vol |
480,000 | |
| Filed 2019-08-08 10:45 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000,000 vol |
12,000,000 | |
| Filed 2019-08-02 11:31 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
||
| Filed 2019-05-10 13:17 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000,000 vol |
||
| Filed 2019-08-02 18:52 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-13,714,285 vol |
571,429 | |
| Filed 2019-08-02 18:51 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-02 18:50 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,714,285 vol |
571,429 | |
| Filed 2019-08-02 13:00 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-02 12:59 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-12,297,600 vol |
512,400 | |
| Filed 2019-08-02 12:57 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,201,792 vol |
258,408 | |
| Filed 2019-08-02 12:18 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-720,000 vol |
30,000 | |
| Filed 2019-08-02 12:17 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Tucker, Joseph Edward Lovell
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-73,223,530 vol |
3,050,980 | |
| Filed 2019-08-02 12:14 Tx date 2019-08-01 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,600
+20,000 vol $0.68 each |
320,000 | |
| Filed 2019-08-02 12:12 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-6,589,715 vol |
274,571 | |
| Filed 2019-08-02 12:11 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-02 12:09 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Seufer-Wasserthal, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,589,715 vol |
274,571 | |
| Filed 2019-08-02 12:05 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Schuetz, Mathias Maximilian
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-274,285 vol |
11,429 | |
| Filed 2019-08-02 12:05 Tx date 2019-08-01 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+20,000 vol $0.75 each |
||
| Filed 2019-08-02 12:03 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Schuetz, Mathias Maximilian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-35,319,085 vol |
1,471,629 | |
| Filed 2019-08-02 12:00 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-11,792,912 vol |
491,371 | |
| Filed 2019-08-02 11:59 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-02 11:57 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
KALANTZIS, FOTIS
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-11,792,912 vol |
491,371 | |
| Filed 2019-08-02 11:48 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Hagel, Jillian Marie
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-137,143 vol |
5,714 | |
| Filed 2019-08-02 11:46 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Hagel, Jillian Marie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-81,196,573 vol |
3,383,191 | |
| Filed 2019-08-02 11:40 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Facchini, Peter James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-137,143 vol |
5,714 | |
| Filed 2019-08-02 11:38 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Facchini, Peter James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-145,656,605 vol |
6,069,025 | |
| Filed 2019-08-02 11:34 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Ericsson, Jerry Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-35,044,800 vol |
1,460,200 | |
| Filed 2019-08-02 11:31 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-02 11:24 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-17,896,792 vol |
745,700 | |
| Filed 2019-08-02 11:21 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-67,309,960 vol |
2,804,582 | |
| Filed 2019-08-01 11:49 Tx date 2019-05-21 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-336,000
-4,800,000 vol $0.07 each |
200,000 | |
| Filed 2019-08-01 11:46 Tx date 2019-05-21 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
$-235,200
-6,720,000 vol $0.035 each |
280,000 | |
| Filed 2019-07-31 16:57 Tx date 2019-07-30 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,375
+25,000 vol $0.85 each |
25,000 | |
| Filed 2019-07-31 16:56 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Talkkari, Troy Tapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-31 16:10 Tx date 2019-07-31 |
$WLLW
Willow Biosciences Inc. |
Lalani, Sadiq
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+20,000 vol $0.75 each |
300,000 | |
| Filed 2019-07-29 20:22 Tx date 2019-07-12 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,250
+5,000 vol $0.85 each |
70,219,542 | |
| Filed 2019-07-29 20:21 Tx date 2019-07-15 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+5,000 vol $0.80 each |
70,224,542 | |
| Filed 2019-07-29 20:19 Tx date 2019-07-24 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+5,000 vol $0.88 each |
70,229,542 | |
| Filed 2019-07-29 20:18 Tx date 2019-07-25 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,300
+5,000 vol $0.86 each |
70,234,542 | |
| Filed 2019-07-29 20:08 Tx date 2019-07-29 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$385.00
+500 vol $0.77 each |
70,235,042 | |
| Filed 2019-07-12 12:31 Tx date 2019-07-11 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,200
+5,000 vol $0.84 each |
70,214,542 | |
| Filed 2019-07-12 12:30 Tx date 2019-07-11 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,150
+5,000 vol $0.83 each |
70,209,542 | |
| Filed 2019-07-12 12:29 Tx date 2019-07-11 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+10,000 vol $0.80 each |
70,204,542 | |
| Filed 2019-07-12 12:28 Tx date 2019-07-10 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+5,000 vol $0.90 each |
70,194,542 | |
| Filed 2019-07-12 12:26 Tx date 2019-07-09 |
$WLLW
Willow Biosciences Inc. |
Peters, Trevor Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+25,000 vol $1.00 each |
70,189,542 |